Cysteine cathepsins in neurological disorders

Molecular Neurobiology

Volumn 49, Issue 2, 2014, Pages 1017-1030

  Pišlar, Anja ^a   Kos, Janko ^a,b  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

^b JO EF STEFAN INSTITUTE   (Slovenia)

Author keywords

Cathepsins; Inflammation; Lysosomal system; Microglia; Neurodegeneration; Neuronal death

Indexed keywords

CATHEPSIN; CYSTATIN; CYSTEINE; CYSTEINE PROTEINASE;

BRAIN CELL; CENTRAL NERVOUS SYSTEM DISEASE; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME ACTIVITY; GENE MUTATION; HUMAN; INFLAMMATION; LYSOSOME; LYSOSOME STORAGE DISEASE; MEMBRANE PERMEABILITY; NERVE DEGENERATION; NEUROLOGIC DISEASE; NONHUMAN; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REVIEW; ANIMAL; BRAIN; METABOLISM; PATHOLOGY; SECRETION (PROCESS);

ANIMALS; BRAIN; CATHEPSINS; CYSTEINE; HUMANS; NERVOUS SYSTEM DISEASES;

EID: 84896549845     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-013-8576-6     Document Type: Review

References (167)

1. Kazantsev AG (2007) Cellular pathways leading to neuronal dysfunction and degeneration. Drug News Perspect 20(8):501-509
2. Cataldo AM, Nixon RA (1990) Enzymatically active lysosomal proteases are associated with amyloid deposits in Alzheimer brain. Proc Natl Acad Sci U S A 87(10):3861-3865
3. Hook VYH (2006) Neuroproteases in peptide neurotransmission and neurodegenerative diseases - applications to drug discovery research. Biodrugs 20(2):105-119
4. Haque A, Banik NL, Ray SK (2008) New insights into the roles of endolysosomal cathepsins in the pathogenesis of Alzheimer's disease: cathepsin inhibitors as potential therapeutics. CNS Neurol Disord-Dr 7(3):270-277
5. Chen JJ, Lin F, Qin ZH (2008) The roles of the proteasome pathway in signal transduction and neurodegenerative diseases. Neurosci Bull 24(3):183-194 (Pubitemid 352020331)
6. Nakanishi H (2003) Neuronal and microglial cathepsins in aging and age-related diseases. Ageing Res Rev 2(4):367-381
7. Reiser J, Adair B, Reinheckel T (2010) Specialized roles for cysteine cathepsins in health and disease. J Clin Invest 120(10):3421-3431
8. Barrett AJ, Rawlings ND (2007) 'Species' of peptidases. Biol Chem 388(11):1151-1157
9. Puente XS, Sanchez LM, Overall CM, Lopez-Otin C (2003) Human and mouse proteases: a comparative genomic approach. Nat Rev Genet 4(7):544-558 (Pubitemid 36781345)
10. Rawlings ND, Tolle DP, Barrett AJ (2004) MEROPS: the peptidase database. Nucleic Acids Res 32(Database issue):D160-D164 (Pubitemid 38081629)
11. Rawlings ND, Barrett AJ, Bateman A (2012) MEROPS: the database of proteolytic enzymes, their substrates and inhibitors. Nucleic Acids Res 40(D1):D343-D350
12. Stoka V, Turk B, Turk V (2005) Lysosomal cysteine proteases: structural features and their role in apoptosis. Iubmb Life 57(4-5):347-353 (Pubitemid 40904263)
13. Turk B, Turk D, Turk V (2000) Lysosomal cysteine proteases: more than scavengers. Bba-Protein Struct Mol 1477(1-2):98-111 (Pubitemid 30119895)
14. Turk V, Turk B, Turk D (2001) Lysosomal cysteine proteases: facts and opportunities. Embo J 20(17):4629-4633 (Pubitemid 32848615)
15. Yasothornsrikul S, Greenbaum D, Medzihradszky KF, Toneff T, Bundey R, Miller R, Schilling B, Petermann I, Dehnert J, Logvinova A, Goldsmith P, Neveu JM, Lane WS, Gibson B, Reinheckel T, Peters C, Bogyo M, Hook V (2003) Cathepsin L in secretory vesicles functions as a prohormone-processing enzyme for production of the enkephalin peptide neurotransmitter. Proc Natl Acad Sci U S A 100(16):9590-9595 (Pubitemid 37033972)
16. Brix K, Dunkhorst A, Mayer K, Jordans S (2008) Cysteine cathepsins: cellular roadmap to different functions. Biochimie 90(2):194-207 (Pubitemid 351172569)
17. Goulet B, Baruch A, Moon NS, Poirier M, Sansregret LL, Erickson A, Bogyo M, Nepveu A (2004) A cathepsin L isoformthat is devoid of a signal peptide localizes to the nucleus in S phase and processes the CDP/Cux transcription factor. Mol Cell 14(2):207-219 (Pubitemid 38515648)
18. Muller S, Dennemarker J, Reinheckel T (2012) Specific functions of lysosomal proteases in endocytic and autophagic pathways. Bba-Proteins Proteom 1824(1):34-43
19. Friedrichs B, Tepel C, Reinheckel T, Deussing J, von Figura K, Herzog V, Peters C, Saftig P, Brix K (2003) Thyroid functions of mouse cathepsins B, K, and L. J Clin Invest 111(11):1733-1745 (Pubitemid 38057754)
20. Funkelstein L, Toneff T, Hwang SR, Reinheckel T, Peters C, Hook V (2008) Cathepsin L participates in the production of neuropeptide Y in secretory vesicles, demonstrated by protease gene knockout and expression. J Neurochem 106(1):384-391 (Pubitemid 351840225)
21. Funkelstein L, Toneff T, Mosier C, Hwang SR, Beuschlein F, Lichtenauer UD, Reinheckel T, Peters C, Hook V (2008) Major role of cathepsin L for producing the peptide hormones ACTH, beta-endorphin, and alpha-MSH, illustrated by protease gene knockout and expression. J Biol Chem 283(51):35652-35659
22. Honey K, Rudensky AY (2003) Lysosomal cysteine proteases regulate antigen presentation. Nat Rev Immunol 3(6):472-482 (Pubitemid 37339187)
23. Chapman HA, Riese RJ, Shi GP (1997) Emerging roles for cysteine proteases in human biology. Annu Rev Physiol 59:63-88. doi:10.1146/annurev.physiol.59.1. 63 (Pubitemid 27142435)
24. Yasuda Y, Kaleta J, Bromme D (2005) The role of cathepsins in osteoporosis and arthritis: rationale for the design of new therapeutics. Adv Drug Deliv Rev 57(7):973-993 (Pubitemid 40703885)
25. Turk B, Stoka V, Rozman-Pungercar J, Cirman T, Droga-Mazovec G, Oreic K, Turk V (2002) Apoptotic pathways: involvement of lysosomal proteases. Biol Chem 383(7-8):1035-1044 (Pubitemid 35215049)
26. Tanabe H, Kumagai N, Tsukahara T, Ishiura S, Kominami E, Nishina H, Sugita H (1991) Changes of lysosomal proteinase activities and their expression in rat cultured keratinocytes during differentiation. Biochim Biophys Acta 1094(3):281-287
27. Kos J, Lah TT (1998) Cysteine proteinases and their endogenous inhibitors: target proteins for prognosis, diagnosis and therapy in cancer (Review). Oncol Rep 5(6):1349-1361 (Pubitemid 28474074)
28. Conus S, Simon HU (2008) Cathepsins: key modulators of cell death and inflammatory responses. Biochem Pharmacol 76(11):1374-1382
29. Kawada A, Hara KJ, Kominami E, Hiruma M, Noguchi H, Ishibashi A (1997) Processing of cathepsins L, B and D in psoriatic epidermis. Arch Dermatol Res 289(2):87-93 (Pubitemid 27075573)
30. Takeda A, Jimi T, Wakayama Y, Misugi N, Miyake S, Kumagai T (1992) Demonstration of cathepsins B, H and L in xenografts of normal and Duchenne-muscular-dystrophy muscles transplanted into nude-mice. Biochem J 288:643-648
31. Liu J, Sukhova GK, Yang JT, Sun JS, Ma LK, Ren A, Xu WH, Fu HX, Dolganov GM, Hu CC, Libby P, Shi GP (2006) Cathepsin L expression and regulation in human abdominal aortic aneurysm, atherosclerosis, and vascular cells. Atherosclerosis 184(2):302-311 (Pubitemid 43049714)
32. Stoch SA, Wagner JA (2008) Cathepsin K inhibitors: a novel target for osteoporosis therapy. Clin Pharmacol Ther 83(1):172-176
33. Halangk W, Lerch MM, Brandt-Nedelev B, Roth W, Ruthenbuerger M, Reinheckel T, Domschke W, Lippert H, Peters C, Deussing J (2000) Role of cathepsin B in intracellular trypsinogen activation and the onset of acute pancreatitis. J Clin Invest 106(6):773-781
34. Kos J, Sekirnik A, Premzl A, Bergant VZ, Langerholc T, Turk B, Werle B, Golouh R, Repnik U, Jeras M, Turk V (2005) Carboxypeptidases cathepsins X and B display distinct protein profile in human cells and tissues. Exp Cell Res 306(1):103-113 (Pubitemid 40692776)
35. Kos J, Jevnikar Z, Obermajer N (2009) The role of cathepsin X in cell signaling. Cell Adhes Migr 3(2):164-166
36. Bernstein HG, Kirschke H, Wiederanders B, Schmidt D, Rinne A (1990) Antigenic expression of cathepsin-B in aged human brain. Brain Res Bull 24(4):543-549 (Pubitemid 20161515)
37. Nakanishi H, Tominaga K, Amano T, Hirotsu I, Inoue T, Yamamoto K (1994) Age-related changes in activities and localizations of cathepsins D, E, B, and L in the rat brain tissues. Exp Neurol 126(1):119-128 (Pubitemid 24131109)
38. Petanceska S, Burke S, Watson SJ, Devi L (1994) Differential distribution of messenger RNAs for cathepsins B, L and S in adult rat brain: an in situ hybridization study. Neuroscience 59(3):729-738 (Pubitemid 24131525)
39. Tang CH, Lee JW, Galvez MG, Robillard L, Mole SE, Chapman HA (2006) Murine cathepsin F deficiency causes neuronal lipofuscinosis and late-onset neurological disease. Mol Cell Biol 26(6):2309-2316 (Pubitemid 43346930)
40. Wendt W, Zhu XR, Lubbert H, Stichel CC (2007) Differential expression of cathepsin X in aging and pathological central nervous system of mice. Exp Neurol 204(2):525-540 (Pubitemid 46497060)
41. Koike M, Shibata M, Ezaki J, Peters C, Saftig P, Kominami E, Uchiyama Y (2013) Differences in expression patterns of cathepsin C/dipeptidyl peptidase I in normal, pathological and aged mouse central nervous system. Eur J Neurosci 37(5):816-830
42. Liuzzo JP, Petanceska SS, Moscatelli D, Devi LA (1999) Inflammatory mediators regulate cathepsin S in macrophages and microglia: a role in attenuating heparan sulfate interactions. Mol Med 5(5):320-333 (Pubitemid 29342967)
43. Funkelstein L, Lu WD, Koch B, Mosier C, Toneff T, Taupenot L, O'Connor DT, Reinheckel T, Peters C, Hook V (2012) Human cathepsin V protease participates in production of enkephalin and NPY neuropeptide neurotransmitters. J Biol Chem 287(19):15232-15241
44. Pope A, Nixon RA (1984) Proteases of human-brain. Neurochem Res 9(3):291-323
45. Spizz G, Blackshear PJ (1997) Identification and characterization of cathepsin B as the cellular MARCKS cleaving enzyme. J Biol Chem 272(38):23833-23842 (Pubitemid 27410963)
46. Hook VYH, Toneff T, Aaron W, Yasothornsrikul S, Bundey R, Reisine T (2002) Beta-amyloid peptide in regulated secretory vesicles of chromaffin cells: evidence for multiple cysteine proteolytic activities in distinct pathways for beta-secretase activity in chromaffin vesicles. J Neurochem 81(2):237-256 (Pubitemid 34809349)
47. Hook VYH, Reisine TD (2003) Cysteine proteases are the major beta-secretase in the regulated secretory pathway that provides most of the beta-amyloid in Alzheimer 's disease: role of BACE 1 in the constitutive secretory pathway. J Neurosci Res 74(3):393-405 (Pubitemid 37362816)
48. Kindy MS, Yu J, Zhu H, El-Amouri SS, Hook V, Hook GR (2012) Deletion of the cathepsin B gene improves memory deficits in a transgenic ALZHeimer's disease mouse model expressing AbetaPP containing the wild-type beta-secretase site sequence. J Alzheimers Dis 29(4):827-840
49. Authier F, Metioui M, Bell AW, Mort JS (1999) Negative regulation of epidermal growth factor signaling by selective proteolytic mechanisms in the endosome mediated by cathepsin B. J Biol Chem 274(47):33723-33731 (Pubitemid 129511688)
50. Authier F, Kouach M, Briand G (2005) Endosomal proteolysis of insulin-like growth factor-I at its C-terminal D-domain by cathepsin B. Febs Lett 579(20):4309-4316 (Pubitemid 41116357)
51. Ryan RE, Sloane BF, Sameni M, Wood PL (1995) Microglial cathepsin-B - an immunological examination of cellular and secreted species. J Neurochem 65(3):1035-1045
52. Kingham PJ, Pocock JM (2001) Microglial secreted cathepsin B induces neuronal apoptosis. J Neurochem 76(5):1475-1484 (Pubitemid 32198252)
53. Schotte P, Van Criekinge W, Van de Craen M, Van Loo G, Desmedt M, Grooten J, Cornelissen M, De Ridder L, Vandekerckhove J, Fiers W, Vandenabeele P, Beyaert R (1998) Cathepsin B-mediated activation of the proinflammatory caspase-11. Biochem Biophys Res Commun 251(1):379-387 (Pubitemid 28498120)
54. Benchoua A, Braudeau J, Reis A, Couriaud C, Onteniente B (2004) Activation of proinflammatory caspases by cathepsin B in focal cerebral ischemia. J Cereb Blood Flow Metab 24(11):1272-1279 (Pubitemid 39482490)
55. Cirman T, Snipas SJ, Ellerby LM, Bredesen D, Freeze H, Abrahamson M, Bromme D, Krajewski S, Reed JC, Yin XM, Turk V, Salvesen GS (2001) Lysosomal protease pathways to apoptosis: cleavage of Bid, not pro-caspases, is the most likely route. J Biol Chem 276(5):3149-3157
56. Cirman T, Oresic K, Mazovec GD, Turk V, Reed JC, Myers RM, Salvesen GS, Turk B (2004) Selective disruption of lysosomes in HeLa cells triggers apoptosis mediated by cleavage of bid by multiple papain-like lysosomal cathepsins. J Biol Chem 279(5):3578-3587 (Pubitemid 38140598)
57. Guicciardi ME, Deussing J, Miyoshi H, Bronk SF, Svingen PA, Peters C, Kaufmann SH, Gores GJ (2000) Cathepsin B contributes to TNF-alpha-mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c. J Clin Invest 106(9):1127-1137
58. Yakovlev AA, Gorokhovatsky AY, Onufriev MV, Beletsky IP, Gulyaeva NV (2008) Brain cathepsin B cleaves a caspase substrate. Biochem-Moscow+ 73(3):332-336 (Pubitemid 351490983)
59. Funkelstein L, Beinfeld M, Minokadeh A, Zadina J, Hook V (2010) Unique biological function of cathepsin L in secretory vesicles for biosynthesis of neuropeptides. Neuropeptides 44(6):457-466
60. Hook V, Funkelstein L, Wegrzyn J, Bark S, Kindy M, Hook G (2012) Cysteine cathepsins in the secretory vesicle produce active peptides: cathepsin L generates peptide neurotransmitters and cathepsin B produces beta-amyloid of Alzheimer's disease. Bba-Proteins Proteom 1824(1):89-104
61. Stahl S, Reinders Y, Asan E, Mothes W, Conzelmann E, Sickmann A, Felbor U (2007) Proteomic-analysis of cathepsin B and L-deficient mouse brain lysosomes. Bba-Proteins Proteom 1774(10):1237-1246 (Pubitemid 47484289)
62. Lu WD, Funkelstein L, Toneff T, Reinheckel T, Peters C, Hook V (2012) Cathepsin H functions as an aminopeptidase in secretory vesicles for production of enkephalin and galanin peptide neurotransmitters. J Neurochem 122(3):512-522
63. Brguljan PM, Turk V, Cimerman N, Brzin J, Krizaj I, Popovic A (2003) Human brain cathepsin H as a neuropeptide and bradykinin metabolizing enzyme. Peptides 24(12):1977-1984 (Pubitemid 38177635)
64. Nagler DK, Menard R (1998) Human cathepsin X: A novel cysteine protease of the papain family with a very short proregion and unique insertions. Febs Lett 434(1-2):135-139 (Pubitemid 28404676)
65. Obermajer N, Doljak B, Kos J (2006) Cysteine cathepsins: regulators of antitumour immune response. Expert Opin Biol Ther 6(12):1295-1309 (Pubitemid 44875684)
66. Obermajer N, Doljak B, Jamnik P, Fonovic UP, Kos J (2009) Cathepsin X cleaves the C-terminal dipeptide of alpha- and gamma-enolase and impairs survival and neuritogenesis of neuronal cells. Int J Biochem Cell B 41(8-9):1685-1696
67. Pišlar AH, Zidar N, Kikelj D, Kos J (2013) Cathepsin X promotes 6-hydroxydopamine-induced apoptosis of PC12 and SH-SY5Y cells. Neuropharmacology. doi:10.1016/j.neuropharm.2013.07.040
68. Petanceska S, Canoll P, Devi LA (1996) Expression of rat cathepsin S in phagocytic cells. J Biol Chem 271(8):4403-4409 (Pubitemid 26070548)
69. Wendt W, Lubbert H, Stichel CC (2008) Upregulation of cathepsin S in the aging and pathological nervous system of mice. Brain Res 1232:7-20
70. Nakanishi H (2003) Microglial functions and proteases. Mol Neurobiol 27(2):163-176
71. Kirschke H, Wiederanders B (1994) Cathepsin-S and related lysosomal endopeptidases. Method Enzymol 244:500-511
72. Kirschke H, Wiederanders B, Bromme D, Rinne A (1989) Cathepsin-S from bovine spleen - purification, distribution, intracellular-localization and action on proteins. Biochem J 264(2):467-473 (Pubitemid 20024516)
73. Maciewicz RA, Etherington DJ (1988) A comparison of four cathepsins (B, L, N and S) with collagenolytic activity from rabbit spleen. Biochem J 256(2):433-440 (Pubitemid 19006004)
74. Shi GP, Munger JS, Meara JP, Rich DH, Chapman HA (1992) Molecular-cloning and expression of human alveolar macrophage cathepsin-S, an elastinolytic cysteine protease. J Biol Chem 267(11):7258-7262
75. Hao HP, Doh-ura K, Nakanishi H (2007) Impairment of microglial responses to facial nerve axotomy in cathepsin S-deficient mice. J Neurosci Res 85(10):2196-2206
76. Lindstedt L, Lee M, Oorni K, Bromme D, Kovanen PT (2003) Cathepsins F and S block HDL3-induced cholesterol efflux from macrophage foam cells. Biochem Biophys Res Commun 312(4):1019-1024 (Pubitemid 37490917)
77. Oorni K, Sneck M, Bromme D, Pentikainen MO, Lindstedt KA, Mayranpaa M, Aitio H, Kovanen PT (2004) Cysteine protease cathepsin F is expressed in human atherosclerotic lesions, is secreted by cultured macrophages, and modifies low density lipoprotein particles in vitro. J Biol Chem 279(33):34776-34784 (Pubitemid 39318110)
78. Cataldo AM, Paskevich PA, Kominami E, Nixon RA (1991) Lysosomal hydrolases of different classes are abnormally distributed in brains of patients with Alzheimer disease. Proc Natl Acad Sci U S A 88(24):10998-11002 (Pubitemid 21915966)
79. Cataldo AM, Hamilton DJ, Nixon RA (1994) Lysosomal abnormalities in degenerating neurons link neuronal compromise to senile plaque development in Alzheimer disease. Brain Res 640(1-2):68-80 (Pubitemid 24086532)
80. Cataldo AM, Hamilton DJ, Barnett JL, Paskevich PA, Nixon RA (1996) Abnormalities of the endosomal-lysosomal system in Alzheimer's disease: relationship to disease pathogenesis. Adv Exp Med Biol 389:271-280
81. Lynch G, Bi XN (2003) Lysosomes and brain aging in mammals. Neurochem Res 28(11):1725-1734 (Pubitemid 37296214)
82. Mantle D, Falkous G, Ishiura S, Perry RH, Perry EK (1995) Comparison of cathepsin protease activities in brain tissue from normal cases and cases with Alzheimer's disease, Lewy body dementia, Parkinson's disease and Huntington's disease. J Neurol Sci 131(1):65-70
83. Nakamura Y, Takeda M, Suzuki H, Morita H, Tada K, Hariguchi S, Nishimura T (1989) Lysosome instability in aged rat brain. Neurosci Lett 97(1-2):215-220 (Pubitemid 19048938)
84. Yamashima T (2000) Implication of cysteine proteases calpain, cathepsin and caspase in ischemic neuronal death of primates. Prog Neurobiol 62(3):273-295
85. Nixon RA, Cataldo AM (1993) The lysosomal system in neuronal cell-death: a review. Ann NY Acad Sci 679:87-109 (Pubitemid 23202401)
86. Felbor U, Kessler B, Mothes W, Goebel HH, Ploegh HL, Bronson RT, Olsen BR (2002) Neuronal loss and brain atrophy in mice lacking cathepsins B and L. Proc Natl Acad Sci U S A 99(12):7883-7888 (Pubitemid 34650974)
87. Nagai A, Murakawa Y, Terashima M, Shimode K, Umegae N, Takeuchi H, Kobayashi S (2000) Cystatin C and cathepsin B in CSF from patients with inflammatory neurologic diseases. Neurology 55(12):1828-1832 (Pubitemid 32103964)
88. Stichel CC, Luebbert H (2007) Inflammatory processes in the aging mouse brain: participation of dendritic cells and T-cells. Neurobiol Aging 28(10):1507-1521 (Pubitemid 47238535)
89. Hafner A, Glavan G, Obermajer N, Zivin M, Schliebs R, Kos J (2013) Neuroprotective role of gamma-enolase in microglia in a mouse model of Alzheimer 's disease is regulated by cathepsin X. Aging Cell 12(4):604-614
90. Bednarski E, Ribak CE, Lynch G (1997) Suppression of cathepsins B and L causes a proliferation of lysosomes and the formation of meganeurites in hippocampus. J Neurosci 17(11):4006-4021 (Pubitemid 27220591)
91. Cataldo AM, Barnett JL, Mann DMA, Nixon RA (1996) Colocalization of lysosomal hydrolase and beta-amyloid in diffuse plaques of the cerebellum and striatum in Alzheimer's disease and Down's syndrome. J Neuropathol Exp Neurol 55(6):704-715 (Pubitemid 26187397)
92. Lemere CA, Munger JS, Shi GP, Natkin L, Haass C, Chapman HA, Selkoe DJ (1995) The lysosomal cysteine protease, cathepsin-S, is increased in Alzheimers-disease and Down syndrome brain: an immunocytochemical study. Am J Pathol 146(4):848-860
93. Ii K, Ito H, Kominami E, Hirano A (1993) Abnormal distribution of cathepsin proteinases and endogenous inhibitors (cystatins) in the hippocampus of patients with Alzheimer 's disease, parkinsonism-dementia complex on Guam, and senile dementia and in the aged. Virchows Arch A Pathol Anat Histopathol 423(3):185-194 (Pubitemid 23309333)
94. Bernstein HG, Kirschke H, Wiederanders B, Pollak KH, Zipress A, Rinne A (1996) The possible place of cathepsins and cystatins in the puzzle of Alzheimer disease: a review. Mol Chem Neuropathol 27(3):225-247 (Pubitemid 26142648)
95. Schechter I, Ziv E (2011) Cathepsins S, B and L with aminopeptidases display beta-secretase activity associated with the pathogenesis of Alzheimer's disease. Biol Chem 392(6):555-569
96. Hook VY, Kindy M, Hook G (2008) Inhibitors of cathepsin B improve memory and reduce beta-amyloid in transgenic Alzheimer disease mice expressing the wild-type, but not the Swedish mutant, beta-secretase site of the amyloid precursor protein. J Biol Chem 283(12):7745-7753
97. Hook G, Hook V, Kindy M (2011) The cysteine protease inhibitor, E64d, reduces brain amyloid-beta and improves memory deficits in Alzheimer's disease animal models by inhibiting cathepsin B, but not BACE1, beta-secretase activity. J Alzheimers Dis 26(2):387-408
98. Hook VY, Kindy M, Reinheckel T, Peters C, Hook G (2009) Genetic cathepsin B deficiency reduces beta-amyloid in transgenic mice expressing human wild-type amyloid precursor protein. Biochem Biophys Res Commun 386(2):284-288
99. Mueller-Steiner S, Zhou Y, Arai H, Roberson ED, Sun BG, Chen J, Wang X, Yu GQ, Esposito L, Mucke L, Gan L (2006) Antiamyloidogenic and neuroprotective functions of cathepsin B: implications for Alzheimer's disease. Neuron 51(6):703-714 (Pubitemid 44374903)
100. Lee S, Sato Y, Nixon RA (2011) Lysosomal proteolysis inhibition selectively disrupts axonal transport of degradative organelles and causes an Alzheimer's-like axonal dystrophy. J Neurosci 31(21):7817-7830
101. Yamashima T, Oikawa S (2009) The role of lysosomal rupture in neuronal death. Prog Neurobiol 89(4):343-358
102. Bendiske J, Bahr BA (2003) Lysosomal activation is a compensatory response against protein accumulation and associated synaptopathogenesis - an approach for slowing Alzheimer disease? J Neuropathol Exp Neurol 62(5):451-463 (Pubitemid 36560187)
103. Munger JS, Haass C, Lemere CA, Shi GP, Wong WSF, Teplow DB, Selkoe DJ, Chapman HA (1995) Lysosomal processing of amyloid precursor protein to a-beta peptides: a distinct role for cathepsin-S. Biochem J 311:299-305
104. Liuzzo JP, Petanceska SS, Devi LA (1999) Neurotrophic factors regulate cathepsin S in macrophages and microglia: a role in the degradation of myelin basic protein and amyloid beta peptide. Mol Med 5(5):334-343 (Pubitemid 29342968)
105. Pike CJ, Burdick D, Walencewicz AJ, Glabe CG, Cotman CW (1993) Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state. J Neurosci 13(4):1676-1687 (Pubitemid 23095409)
106. Brunk U, Brun A (1972) The effect of aging on lysosomal permeability in nerve cells of the central nervous system. An enzyme histochemical study in rat. Histochemie 30(4):315-324
107. Bahr BA, Bendiske J (2002) The neuropathogenic contributions of lysosomal dysfunction. J Neurochem 83(3):481-489 (Pubitemid 35231802)
108. Tardy C, Andrieu-Abadie N, Salvayre R, Levade T (2004) Lysosomal storage diseases: is impaired apoptosis a pathogenic mechanism? Neurochem Res 29(5):871-880 (Pubitemid 39011337)
109. Nixon RA, Cataldo AM (2006) Lysosomal system pathways: genes to neurodegeneration in Alzheimer 's disease. J Alzheimers Dis 9(3 Suppl):277-289 (Pubitemid 44253321)
110. Vellodi A (2005) Lysosomal storage disorders. Br J Haematol 128(4):413-431
111. Koike M, Shibata M, Waguri S, Yoshimura K, Tanida I, Kominami E, Gotow T, Peters C, von Figura K, Mizushima N, Saftig P, Uchiyama Y (2005) Participation of autophagy in storage of lysosomes in neurons from mouse models of neuronal ceroidlipofuscinoses (Batten disease). Am J Pathol 167(6):1713-1728 (Pubitemid 41713322)
112. Nitatori T, Sato N, Waguri S, Karasawa Y, Araki H, Shibanai K, Kominami E, Uchiyama Y (1995) Delayed neuronal death in the CA1 pyramidal cell layer of the gerbil hippocampus following transient ischemia is apoptosis. J Neurosci 15(2):1001-1011
113. Amritraj A, Peake K, Kodam A, Salio C, Merighi A, Vance JE, Kar S (2009) Increased activity and altered subcellular distribution of lysosomal enzymes determine neuronal vulnerability in Niemann-Pick type C1-deficient mice. Am J Pathol 175(6):2540-2556
114. McGeer PL, Itagaki S, Boyes BE, McGeer EG (1988) Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology 38(8):1285-1291
115. Amano T, Nakanishi H, Kondo T, Tanaka T, Oka M, Yamamoto K (1995) Age-related changes in cellular localization and enzymatic activities of cathepsins B, L and D in the rat trigeminal ganglion neuron. Mech Ageing Dev 83(3):133-141
116. Wendt W, Schulten R, Stichel CC, Lubbert H (2009) Intra- versus extracellular effects of microglia-derived cysteine proteases in a conditioned medium transfer model. J Neurochem 110(6):1931-1941
117. Batchelor PE, Liberatore GT, Wong JYF, Porritt MJ, Frerichs F, Donnan GA, Howells DW (1999) Activated macrophages and microglia induce dopaminergic sprouting in the injured striatum sand express brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor. J Neurosci 19(5):1708-1716 (Pubitemid 29094189)
118. Gonzalez-Scarano F, Baltuch G (1999) Microglia as mediators of inflammatory and degenerative diseases. Annu Rev Neurosci 22:219-240 (Pubitemid 29144887)
119. Fan K, Wu XF, Fan B, Li N, Lin YZ, Yao YW, Ma JM (2012) Upregulation of microglial cathepsin C expression and activity in lipopolysaccharide-induced neuroinflammation. J Neuroinflammation 9:96
120. Czapski GA, Gajkowska B, Strosznajder JB (2010) Systemic administration of lipopolysaccharide induces molecular and morphological alterations in the hippocampus. Brain Res 1356:85-94
121. Matyszak MK, Perry VH (1996) The potential role of dendritic cells in immune-mediated inflammatory diseases in the central nervous system. Neuroscience 74(2):599-608 (Pubitemid 26274227)
122. Pashenkov M, Teleshova N, Link H (2003) Inflammation in the central nervous system: the role for dendritic cells. Brain Pathol 13(1):23-33 (Pubitemid 36133789)
123. Beck H, Schwarz G, Schroter CJ, Deeg M, Baier D, Stevanovic S, Weber E, Driessen C, Kalbacher H (2001) Cathepsin S and an asparagine-specific endoprotease dominate the proteolytic processing of human myelin basic protein in vitro. Eur J Immunol 31(12):3726-3736 (Pubitemid 34030986)
124. Fissolo N, Kraus M, Reich M, Ayturan M, Overkleeft H, Driessen C, Weissert R (2008) Dual inhibition of proteasomal and lysosomal proteolysis ameliorates autoimmune central nervous system inflammation. Eur J Immunol 38(9):2401-2411
125. Pradhan S, Andreasson K (2013) Commentary: Progressive inflammation as a contributing factor to early development of Parkinson's disease. Exp Neurol 241:148-155
126. Lotharius J, Brundin P (2002) Pathogenesis of Parkinson's disease: dopamine, vesicles and alpha-synuclein. Nat Rev Neurosci 3(12):932-942
127. Chung KK, Dawson VL, Dawson TM (2003) New insights into Parkinson's disease. J Neurol 250(Suppl 3):III15-III24
128. Lee DC, Close FT, Goodman CB, Jackson IM, Wight-Mason C, Wells LM, Womble TA, Palm DE (2006) Enhanced cystatin C and lysosomal protease expression following 6-hydroxydopamine exposure. Neurotoxicology 27(2):260-276 (Pubitemid 43212834)
129. Li LY, Wang XX, Fei XF, Xia LP, Qin ZH, Liang ZQ (2011) Parkinson's disease involves autophagy and abnormal distribution of cathepsin L. Neurosci Lett 489(1):62-67
130. Xiang B, Fei XF, Zhuang WZ, Fang Y, Qin ZH, Liang ZQ (2011) Cathepsin L is involved in 6-hydroxydopamine induced apoptosis of SH-SY5Y neuroblastoma cells. Brain Res 1387:29-38
131. Akopyan T (1991) Protein inhibitors of proteinases from brain. Neurochem Res 16(5):513-517
132. Avanzo P, Sabotic J, Anzlovar S, Popovic T, Leonardi A, Pain RH, Kos J, Brzin J (2009) Trypsin-specific inhibitors from the basidiomycete Clitocybe nebularis with regulatory and defensive functions. Microbiol-Sgm 155:3971-3981
133. Lenarcic B, Bevec T (1998) Thyropins - New structurally related proteinase inhibitors. Biol Chem 379(2):105-111 (Pubitemid 28075969)
134. Bevec T, Stoka V, Pungercic G, Dolenc I, Turk V (1996) Major histocompatibility complex class II-associated p41 invariant chain fragment is a strong inhibitor of lysosomal cathepsin L. J Exp Med 183(4):1331-1338 (Pubitemid 26134276)
135. Bevec T, Stoka V, Pungercic G, Cazzulo JJ, Turk V (1997) A fragment of the major histocompatibility complex class II-associated p41 invariant chain inhibits cruzipain, the major cysteine proteinase from Trypanosoma cruzi. Febs Lett 401(2-3):259-261 (Pubitemid 27056128)
136. Abrahamson M, Barrett AJ, Salvesen G, Grubb A (1986) Isolation of six cysteine proteinase inhibitors from human urine. Their physicochemical and enzyme kinetic properties and concentrations in biological fluids. J Biol Chem 261(24):11282-11289 (Pubitemid 17216735)
137. Bode W, Engh R, Musil D, Thiele U, Huber R, Karshikov A, Brzin J, Kos J, Turk V (1988) The 2.0 a X-Ray crystal-structure of chicken egg-white cystatin and its possiblemode of interaction with cysteine proteinases. Embo J 7(8):2593-2599
138. Alvarez-Fernandez M, Barrett AJ, Gerhartz B, Dando PM, Ni JA, Abrahamson M (1999) Inhibition of mammalian legumain by some cystatins is due to a novel second reactive site. J Biol Chem 274(27):19195-19203
139. Brown WM, Dziegielewska KM (1997) Friends and relations of the cystatin superfamily - new members and their evolution. Protein Sci 6(1):5-12 (Pubitemid 27045239)
140. Laitala-Leinonen T, Rinne R, Saukko P, Vaananen HK, Rinne A (2006) Cystatin B as an intracellular modulator of bone resorption. Matrix Biol 25(3):149-157
141. Colbert JD, Matthews SP, Miller G, Watts C (2009) Diverse regulatory roles for lysosomal proteases in the immune response. Eur J Immunol 39(11):2955-2965
142. Wallin H, Bjarnadottir M, Vogel LK, Wasselius J, Ekstrom U, Abrahamson M (2010) Cystatins - Extra- and intracellular cysteine protease inhibitors: high-level secretion and uptake of cystatin C in human neuroblastoma cells. Biochimie 92(11):1625-1634
143. Langerholc T, Zavasnik-Bergant V, Turk B, Turk V, Abrahamson M, Kos J (2005) Inhibitory properties of cystatin F and its localization in U937 promonocyte cells. Febs J 272(6):1535-1545 (Pubitemid 40444941)
144. Magister S, Obermajer N, Mirkovic B, Svajger U, Renko M, Softic A, Romih R, Colbert JD, Watts C, Kos J (2012) Regulation of cathepsins S and L by cystatin F during maturation of dendritic cells. Eur J Cell Biol 91(5):391-401
145. Premzl A, Zavasnik-Bergant V, Turk V, Kos J (2003) Intracellular and extracellular cathepsin B facilitate invasion of MCF-10A neoT cells through reconstituted extracellular matrix in vitro. Exp Cell Res 283(2):206-214 (Pubitemid 36269026)
146. Sundelof J, Arnlov J, Ingelsson E, Sundstrom J, Basu S, Zethelius B, Larsson A, Irizarry MC, Giedraitis V, Ronnemaa E, Degerman-Gunnarsson M, Hyman BT, Basun H, Kilander L, Lannfelt L (2008) Serum cystatin C and the risk of Alzheimer disease in elderly men. Neurology 71(14):1072-1079
147. Sun BG, Zhou YG, Halabisky B, Lo I, Cho SH, Mueller-Steiner S, Devidze N, Wang X, Grubb A, Gan L (2008) Cystatin C-cathepsin B axis regulates amyloid beta levels and associated neuronal deficits in an animal model of Alzheimer's disease. Neuron 60(2):247-257
148. Kaeser SA, Herzig MC, Coomaraswamy J, Kilger E, Selenica ML, Winkler DT, Staufenbiel M, Levy E, Grubb A, Jucker M (2007) Cystatin C modulates cerebral beta-amyloidosis. Nat Genet 39(12):1437-1439
149. Irani DN, Anderson C, Gundry R, Cotter R, Moore S, Kerr DA, McArthur JC, Sacktor N, Pardo CA, Jones M, Calabresi PA, Nath A (2006) Cleavage of cystatin C in the cerebrospinal fluid of patients with multiple sclerosis. Ann Neurol 59(2):237-247 (Pubitemid 43202476)
150. Hansson SF, Simonsen AH, Zetterberg H, Andersen O, Haghighi S, Fagerberg I, Andreasson U, Westman-Brinkmalm A, Wallin A, Ruetschi U, Blennow K (2007) Cystatin C in cerebrospinal fluid and multiple sclerosis. Ann Neurol 62(2):193-196 (Pubitemid 47546505)
151. Xu L, Sheng JS, Tang ZS, Wu XF, Yu Y, Guo H, Shen Y, Zhou CF, Paraoan L, Zhou JW (2005) Cystatin C prevents degeneration of rat nigral dopaminergic neurons: in vitro and in vivo studies. Neurobiol Dis 18(1):152-165 (Pubitemid 40092905)
152. Wilson ME, Boumaza I, Lacomis D, Bowser R (2010) Cystatin C: a candidate biomarker for amyotrophic lateral sclerosis. Plos One 5(12):e15133
153. D'Adamio L (2010) Role of Cystatin C in neuroprotection and its therapeutic implications. Am J Pathol 177(5):2163-2165
154. Pennacchio LA, Lehesjoki AE, Stone NE, Willour VL, Virtaneva K, Miao J, D'Amato E, Ramirez L, Faham M, Koskiniemi M, Warrington JA, Norio R, de la Chapelle A, Cox DR, Myers RM (1996) Mutations in the gene encoding cystatin B in progressive myoclonus epilepsy (EPM1). Science 271(5256):1731-1734 (Pubitemid 26102822)
155. Lalioti MD, Scott HS, Buresi C, Rossier C, Bottani A, Morris MA, Malafosse A, Antonarakis SE (1997) Dodecamer repeat expansion in cystatin B gene in progressive myoclonus epilepsy. Nature 386(6627):847-851 (Pubitemid 27181260)
156. Kaur G, Mohan P, Pawlik M, DeRosa S, Fajiculay J, Che SL, Grubb A, Ginsberg SD, Nixon RA, Levy E (2010) Cystatin C rescues degenerating neurons in a cystatin B-knockout mouse model of progressive myoclonus epilepsy. Am J Pathol 177(5):2256-2267
157. Houseweart MK, Pennacchio LA, Vilaythong A, Peters C, Noebels JL, Myers RM (2003) Cathepsin B but not cathepsins L or S contributes to the pathogenesis of Unverricht-Lundborg progressive myoclonus epilepsy (EPM1). J Neurobiol 56(4):315-327 (Pubitemid 37010940)
158. Polajnar M, Ceru S, Kopitar-Jerala N, Zerovnik E (2012) Human stefin B normal and patho-physiological role: molecular and cellular aspects of amyloid-type aggregation of certain EPM1 mutants. Front Mol Neurosci 5:88
159. Revesz T, Holton JL, Lashley T, Plant G, Frangione B, Rostagno A, Ghiso J (2009) Genetics and molecular pathogenesis of sporadic and hereditary cerebral amyloid angiopathies. Acta Neuropathol 118(1):115-130
160. Cohen DH, Feiner H, Jensson O, Frangione B (1983) Amyloid fibril in hereditary cerebral-hemorrhage with amyloidosis (HCHWA) is related to the gastroentero-pancreatic neuroendocrine protein, gamma trace. J Exp Med 158(2):623-628 (Pubitemid 13049413)
161. Wei LH, Berman Y, Castano EM, Cadene M, Beavis RC, Devi L, Levy E (1998) Instability of the amyloidogenic cystatin C variant of hereditary cerebral hemorrhage with amyloidosis, Icelandic type. J Biol Chem 273(19):11806-11814 (Pubitemid 28272086)
162. Hook G, Hook VY, Kindy M (2007) Cysteine protease inhibitors reduce brain beta-amyloid and beta-secretase activity in vivo and are potential Alzheimer's disease therapeutics. Biol Chem 388(9):979-983 (Pubitemid 47258539)
163. Hook V, Hook G, Kindy M (2010) Pharmacogenetic features of cathepsin B inhibitors that improve memory deficit and reduce beta-amyloid related to Alzheimer 's disease. Biol Chem 391(8):861-872
164. Van Broeck B, Van Broeckhoven C, Kumar-Singh S (2007) Current insights into molecular mechanisms of Alzheimer disease and their implications for therapeutic approaches. Neurodegener Dis 4(5):349-365 (Pubitemid 47123462)
165. Kikuchi H, Yamada T, Furuya H, Doh-ura K, Ohyagi Y, Iwaki T, Kira J (2003) Involvement of cathepsin B in the motor neuron degeneration of amyotrophic lateral sclerosis. Acta Neuropathol 105(5):462-468 (Pubitemid 36798842)
166. Ratovitski T, Chighladze E, Waldron E, Hirschhorn RR, Ross CA (2011) Cysteine proteases bleomycin hydrolase and cathepsin Z mediate N-terminal proteolysis and toxicity of mutant huntingtin. J Biol Chem 286(14):12578-12589
167. Liang Q, Ouyang X, Schneider L, Zhang J (2011) Reduction of mutant huntingtin accumulation and toxicity by lysosomal cathepsins D and B in neurons. Mol Neurodegener 6:37